Alzheimer's & Dementia: The Journal of the Alzheimer's Association

Slides:

Advertisements

Similar presentations

2015 Alzheimer's disease facts and figures Alzheimer's & Dementia: The Journal of the Alzheimer's Association Volume 11, Issue 3, Pages (March.

Advertisements

Sleep disruption changes across the disease trajectory: Pilot findings from the healthy patterns sleep study Nancy A. Hodgson, Albert J. Safi Alzheimer's.

DIAGNOSTIC ACCURACY AND CONFIDENCE IN THE CLINICAL DETECTION OF COGNITIVE IMPAIRMENT IN EARLY-STAGE PARKINSON’S DISEASE Kathryn A. Wyman-Chick, Phillip.

Relationship between Microstructural Degeneration of the Corpus Callosum, White Matter Hyperintensities, and Motor Function in Cognitively Intact Elderly

Discriminatory and predictive capabilities of enzyme-linked immunosorbent assay and multiplex platforms in a longitudinal Alzheimer’s disease study Wesley.

Hilkka Liedes, Jyrki Lötjönen, Gerald P. Novak, Mark Forrest Gordon

Alzheimer's & Dementia: The Journal of the Alzheimer's Association

Cerebrospinal fluid levels of the synaptic protein neurogranin correlates with cognitive decline in prodromal Alzheimer's disease Hlin Kvartsberg, Flora.

A SYSTEMATIC REVIEW AND META-ANALYSIS COMPARING QUALITY-OF-LIFE RATINGS FROM FAMILY AND PAID CAREGIVERS OF PEOPLE WITH DEMENTIA RESIDING IN CARE HOMES

Flora H. Duits, Niels D. Prins, Afina W. Lemstra, Yolande A. L

Alzheimer's & Dementia: The Journal of the Alzheimer's Association

Trajectory of multi-dimensional caregiving burden in chinese informal caregivers for dementia: Evidence from exploratory and confirmatory factor analysis.

Alzheimer's & Dementia: The Journal of the Alzheimer's Association

INCREASED CSF LEVELS OF BIOMARKERS FOR NEURODEGENERATION IN FTLD-GRN MUTATION CARRIERS Joery Goossens, Sara Van Mossevelde, Tobi Van den Bossche, Anne.

Localization of Hippocampal atrophy in Alzheimer's disease

Alzheimer's & Dementia: The Journal of the Alzheimer's Association

Cerebrospinal fluid Aβ42 is the best predictor of clinical progression in patients with subjective complaints Argonde C. van Harten, Pieter Jelle Visser,

Alzheimer's biomarkers in daily practice (ABIDE) project: Rationale and design Arno de Wilde, Ingrid S. van Maurik, Marleen Kunneman, Femke Bouwman, Marissa.

Sietske A. M. Sikkes, Elly S. M. de Lange-de Klerk, Yolande A. L

Alzheimer's & Dementia: The Journal of the Alzheimer's Association

Alzheimer's & Dementia: The Journal of the Alzheimer's Association

Alzheimer's & Dementia: The Journal of the Alzheimer's Association

A NOVEL NEUROIMAGING APPROACH TO CAPTURE COGNITIVE RESERVE

Christine Bredfeldt, Kristen Rice, Lisa Alecxih

Comparison of tract-based spatial statistics and ROI-based approach in analyzing the white matter integrity in the elderly Huali Wang, Daniel Chang,

SMARTPHONE TECHNOLOGY TO MEASURE HEALTH CHARACTERISTICS IN OFFSPRING OF PATIENTS WITH DEMENTIA: THE IVITALITY PROOF-OF- PRINCIPLE STUDY Liselotte Wijsman,

Alzheimer's & Dementia: The Journal of the Alzheimer's Association

KETOGENIC DIET EFFECTS ON BRAIN KETONE METABOLISM AND ALZHEIMER'S DISEASE CSF BIOMARKERS Suzanne Craft, Bryan J. Neth, Akiva Mintz, Kiran Sai, Nora Shively,

The effect of using a conditional discrimination procedure to teach name-face relation to a person diagnosed with dementia Hanna S. Steingrimsdottir,

Application of Resource Utilization in Dementia (RUD) instrument in a global setting Anders Wimo, Anders Gustavsson, Linus Jönsson, Bengt Winblad, Ming-Ann.

Alzheimer’s disease core biomarkers and prediction of dementia in MCI: The effect of age at onset Anna Caroli, Samantha Galluzzi, Clarissa Ferrari, Annapaola.

DATA-DRIVEN TAU-PET COVARIANCE NETWORKS ENHANCE PREDICTION OF RETROSPECTIVE COGNITIVE CHANGE IN ALZHEIMER’S DISEASE Jacob W. Vogel, Niklas Mattsson,

Figure 1. Melatonin levels in CSF of control subjects (n = 82) and AD patients (n = 85). *, P< Decreased Melatonin Levels in Postmortem Cerebrospinal.

APOE GENOTYPE MODIFIES THE EFFECTS OF AEROBIC TRAINING ON BRAIN GLUCOSE METABOLISM IN SUBJECTS WITH MILD COGNITIVE IMPAIRMENT Fabio H.G. Porto, Artur.

HYPERGLYCEMIA: PREDISPOSITION FOR MICROEMBOLI, STROKE, AND WHITE MATTER CHANGES Leila Parand, Saif Bushnaq, Yue Wang, Lenora Mathes, Dinesh Jillella,

DETECTING COGNITIVE DISORDERS USING THE MUISTIKKO WEB-BASED COGNITIVE TEST BATTERY: VALIDATION IN THREE COHORTS Teemu Paajanen, Shadi Mahdiani, Marie.

Marjolein Bulk, Linda van der Graaf, Walid M

Cerebral amyloid angiopathy, neurodegeneration, and dementia in a population-based study on the very elderly Finns (Vantaa 85+) Maarit Tanskanen, Mira.

Colin Groot, Chris W. J. van der Weijden, Wiesje M

Thinner temporal and parietal cortex is related to incident clinical progression to dementia in patients with subjective cognitive decline Sander C.J.

Alzheimer's & Dementia: The Journal of the Alzheimer's Association

Japanese brain bank network for neuroscience research

Community environment and incident dementia: Results from the three-city study Claudine Berr, Laure Anne Gutierrez, Sylvaine Artero, Catherine Helmer,

Pairwise gene-protein association analysis on CSF proteomics in the ADNI-1 cohort Sungeun Kim, Shanker Swaminathan, Kwangsik Ngo, Shannon Risacher, Li.

Prevalence and incidence of clinically diagnosed Alzheimer's disease dementia from 1994 to 2012 in a population study Kumar B. Rajan, Jennifer Weuve,

Application of Resource Utilization in Dementia (RUD) instrument in a global setting Anders Wimo, Anders Gustavsson, Linus Jönsson, Bengt Winblad, Ming-Ann.

Prevalence and incidence of clinically diagnosed Alzheimer's disease dementia from 1994 to 2012 in a population study Kumar B. Rajan, Jennifer Weuve,

LIFESPAN OF ONE FOCUSED ULTRASOUND MEDIATED BLOOD-BRAIN BARRIER TREATMENT IN A MOUSE MODEL OF ALZHEIMER'S DISEASE Charissa Poon, Kullervo Hynynen Alzheimer's.

Summary of the evidence on modifiable risk factors for cognitive decline and dementia: A population-based perspective Matthew Baumgart, Heather M. Snyder,

Shruti Mishra, Brian Andrew Gordon, Karl A

Comparison of visual and quantitative florbetapir-PET reads in subjects with early Alzheimer's disease for assessing amyloid burden Bradley Wyman, Yahong.

Alzheimer's & Dementia: The Journal of the Alzheimer's Association

Alzheimer's & Dementia: The Journal of the Alzheimer's Association

Linus Jönsson, Pei-Jung Lin, Ara S. Khachaturian

Alzheimer's & Dementia: The Journal of the Alzheimer's Association

Added value of 11C-PiB-PET imaging in the diagnosis of Alzheimer's disease Kristian Frederiksen, Anne-Mette Hejl, Ian Law, Steen Hasselbalch, Gunhild.

Mark D. Meadowcroft, Douglas G. Peters, Carson J

Alzheimer's & Dementia: The Journal of the Alzheimer's Association

Journal of Investigative Dermatology

COGNITIVE COMPLAINTS IN OLDER ADULTS AT RISK FOR ALZHEIMER’S DISEASE ARE ASSOCIATED WITH ALTERED RESTING STATE NETWORKS Joey A. Contreras, Joaquín Goñi,

Alzheimer's & Dementia: The Journal of the Alzheimer's Association

Alzheimer's & Dementia: The Journal of the Alzheimer's Association

GREY MATTER CONNECTIVITY IS ASSOCIATED WITH CLINICAL PROGRESSION IN NON-DEMENTED, AMYLOID POSITIVE PATIENTS Betty M. Tijms, Mara ten Kate, Sander C.J.

Intersite variability of CSF Alzheimer’s disease biomarkers in clinical setting Julien Dumurgier, Olivier Vercruysse, Claire Paquet, Stéphanie Bombois,

Alzheimer's Association towards Guidelines for Dementia Care Practice: Recommendations with emphasis on high-quality, person-centered care in long-term.

Alzheimer's & Dementia: The Journal of the Alzheimer's Association

Automated detection of beta-amyloid–related cortical and subcortical signal changes in a transgenic model of Alzheimer's disease using high-field MRI

BRAIN AMYLOIDOSIS AND COGNITIVE DECLINE IN MCI: 12-MONTH FOLLOW-UP

Michael Navitsky, Abhinay D. Joshi, Michael D. Devous, Michael J

ONE-YEAR GLOBAL OUTCOME OF A COMPREHENSIVE, INDIVIDUALIZED, PERSON CENTERED MANAGEMENT (CI-PCM) PROGRAM + MEMANTINE IN ADVANCED AD: A RANDOMIZED CONTROLLED.

Presentation transcript:

Alzheimer's & Dementia: The Journal of the Alzheimer's Association Are relations between ApoE genotype and ad-related pathology in nondemented elderly mediated by CSF apolipoproteins? Rosalinde E.R. Slot, Maartje I Kester, Argonde Van Harten, Wesley Jongbloed, Femke Bouwman, Charlotte E. Teunissen, Philip Scheltens, Wiesje M. van der Flier, Robert Veerhuis Alzheimer's & Dementia: The Journal of the Alzheimer's Association Volume 11, Issue 7, (July 2015) DOI: 10.1016/j.jalz.2015.06.939 Copyright © 2015 Terms and Conditions

Figure 1 Associations between APOE e4 carriership and Abeta, Tau and apolipoproteins CSFTaut ] APOE e4 + carriership Alzheimer's & Dementia: The Journal of the Alzheimer's Association 2015 11, DOI: (10.1016/j.jalz.2015.06.939) Copyright © 2015 Terms and Conditions